Cerebrospinal Fluid Protein Profiles in Alzheimer's Dementia Patients: A Bioinformatic Approach.
作者信息
Misra Anamika, Chakrabarti Sankha S, Gambhir Indrajeet S, Baghel Meghraj S, Patil Yugendra R
机构信息
Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):611-613. doi: 10.4103/aian.aian_206_23. Epub 2023 Jul 6.
Abstract
摘要
相似文献
1
Cerebrospinal Fluid Protein Profiles in Alzheimer's Dementia Patients: A Bioinformatic Approach.阿尔茨海默病痴呆患者的脑脊液蛋白质谱：一种生物信息学方法。
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):611-613. doi: 10.4103/aian.aian_206_23. Epub 2023 Jul 6.
2
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.患者脑脊液中的 tau 和淀粉样蛋白-β1-42。
Brain. 2015 Sep;138(Pt 9):2716-31. doi: 10.1093/brain/awv181. Epub 2015 Jun 30.
3
Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.用于脑淀粉样血管病的脑脊液生物标志物。
Brain Commun. 2023 May 19;5(3):fcad159. doi: 10.1093/braincomms/fcad159. eCollection 2023.
4
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.脑脊液神经颗粒蛋白：与阿尔茨海默病认知及神经退行性变的关系
Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.
5
A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.脑脊液中的硒物种可预测轻度认知障碍患者向阿尔茨海默病痴呆的转化。
Alzheimers Res Ther. 2017 Dec 19;9(1):100. doi: 10.1186/s13195-017-0323-1.
6
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.突触前囊泡蛋白突触结合蛋白是阿尔茨海默病的一种新型生物标志物。
Alzheimers Res Ther. 2016 Oct 3;8(1):41. doi: 10.1186/s13195-016-0208-8.
7
Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice.阿尔茨海默病患者及淀粉样前体蛋白敲入小鼠突触改变的转化潜力
Brain Commun. 2023 Jan 5;5(1):fcad001. doi: 10.1093/braincomms/fcad001. eCollection 2023.
8
Association between Longitudinal Cerebrospinal Fluid Alzheimer's Biomarkers and the Lifestyle for Brain Health (LIBRA) Index: Findings from the European Prevention of Alzheimer's Dementia Cohort Study (EPAD LCS).纵向脑脊液阿尔茨海默病生物标志物与大脑健康生活方式（LIBRA）指数之间的关联：来自欧洲预防阿尔茨海默病痴呆症队列研究（EPAD LCS）的结果。
J Prev Alzheimers Dis. 2023;10(3):543-550. doi: 10.14283/jpad.2023.31.
9
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.阿尔茨海默病中脑脊液淀粉样蛋白-β与氟代硼吡咯（florbetapir）成像的独立信息
Brain. 2015 Mar;138(Pt 3):772-83. doi: 10.1093/brain/awu367. Epub 2014 Dec 24.
10
IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.白细胞介素-15在阿尔茨海默病和额颞叶痴呆患者的脑脊液中升高。
J Geriatr Psychiatry Neurol. 2006 Jun;19(2):114-7. doi: 10.1177/0891988706286226.
本文引用的文献
1
A comprehensive systematic review of CSF proteins and peptides that define Alzheimer's disease.对定义阿尔茨海默病的脑脊液蛋白质和肽进行的全面系统综述。
Clin Proteomics. 2020 Jun 5;17:21. doi: 10.1186/s12014-020-09276-9. eCollection 2020.
2
Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies.阿尔茨海默病与糖尿病：胰岛素信号作为连接两种病理的桥梁。
Mol Neurobiol. 2020 Apr;57(4):1966-1977. doi: 10.1007/s12035-019-01858-5. Epub 2020 Jan 3.
3
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.对脑脊液进行定量蛋白质组学分析，以鉴定阿尔茨海默病的候选生物标志物。
Proteomics Clin Appl. 2019 Jul;13(4):e1800105. doi: 10.1002/prca.201800105. Epub 2019 Jan 25.
4
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.散发性阿尔茨海默病的代谢风险因素：对病理学、发病机制及治疗的启示
Aging Dis. 2015 Aug 1;6(4):282-99. doi: 10.14336/AD.2014.002. eCollection 2015 Aug.
5
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议简介。
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.
6
Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.蛋白聚糖和糖胺聚糖在阿尔茨海默病及相关疾病发病机制中的作用：淀粉样蛋白生成和治疗策略——综述。
J Neurosci Res. 2010 Aug 15;88(11):2303-15. doi: 10.1002/jnr.22393.
7
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.抑制凝血酶活性可改善 2 型糖尿病 db/db 小鼠的胰岛素抵抗。
Endocrinology. 2010 Feb;151(2):513-9. doi: 10.1210/en.2009-0661. Epub 2009 Dec 4.
8
Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.症状性和无症状性患者的阿尔茨海默病生物标志物发现：实验方法和未来的临床应用。
Exp Gerontol. 2010 Jan;45(1):15-22. doi: 10.1016/j.exger.2009.09.007. Epub 2009 Sep 29.
9
Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.载脂蛋白 E 异构体与硫酸乙酰肝素和硫酸皮肤素结合的 N 端和 C 端结构域的作用：表面等离子体共振研究。
Biochemistry. 2008 Jun 24;47(25):6702-10. doi: 10.1021/bi8003999.
10
AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects.α1-抗胰蛋白酶基因标签单核苷酸多态性与2型糖尿病和血脂异常相关：对7683名丹麦白人受试者代谢特征的研究
Diabetes. 2008 May;57(5):1427-32. doi: 10.2337/db07-0558. Epub 2008 Mar 3.
Zotero 插件